APOC3 and coronary atherosclerosis: This is especially important, since loss-of-function mutations in the apoC-III gene (APOC3) have been associated with decreased plasma TG, reduced coronary atherosclerosis, and a lower risk of ischemic CVD [48,49], findings that have spurred the development of new therapies to target this multifunctional apolipoprotein [50,51].